Swiss flagship project harnesses AI and sensors for diabetes prevention
Type 2 diabetes generates high healthcare costs in Switzerland and causes significant suffering for those affected. A multidisciplinary…
Does Big Pharma Deserve All the Hate?
This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers,…
Swiss centenarians show youthful blood protein profiles in aging study
In Switzerland, 0.02% of the population lives beyond the age of 100. Could there be biological characteristics associated…